4029-65-6Relevant academic research and scientific papers
Bufalin riboside having selective inhibition action to Na+/K+-ATPase alpha2 subtype and application of bufalin riboside
-
Paragraph 0036; 0037, (2016/12/07)
The invention belongs to the technical field of preparation of cardiotonic drugs, and discloses bufalin riboside having selective inhibition action to Na+/K+-ATPase alpha2 subtype and an application of the bufalin riboside. The structural formula of the bufalin riboside is as shown in the formula (I).Synthesis of the bufalin riboside is carried out for the first time. The bufalin riboside is high in safety and high in cardiotonic effect, can be prepared into different form of drugs, has good medicinal prospect, has the advantages of preparation simplicity, low cost and high productivity; and its selectivity to alpha1 and alpha2 subtypes is up to 17.0.
BUFADIENOLIDE DERIVATIVES, PREPARING PROCESS THEREOF, COMPOSITION COMPRISING THE SAME AND THE USE THEREOF
-
Page/Page column 20-21, (2013/02/28)
The present invention provides a class of bufadienolide derivatives representing by the following formula I or pharmaceutically acceptable salts thereof, the preparing process thereof, pharmaceutical composition comprising the same and the use thereof. The bufadienolide derivatives have inhibitory activities against human-derived tumor cell lines, and thus can be used as a drug for treating malignancies.
